Journal
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES
Volume 8, Issue 10, Pages 1420-1430Publisher
IVYSPRING INT PUBL
DOI: 10.7150/ijbs.5273
Keywords
Inhibitory receptors; CTLA-4; PD-1; BTLA; immunotherapy
Categories
Funding
- Public Technology Research and Social Development Project of Zhejiang Province [20011C23004]
- Zhejiang Provincial Natural Science Foundation of China [LY12B02019]
Ask authors/readers for more resources
T lymphocytes require signaling by the T cell receptor and by nonclonotypic cosignaling receptors. The costimulatory and inhibitory signals profoundly influence the course of immune responses by amplifying or reducing the transcriptional effects of T cell receptor triggering. The inhibitory receptors such as CTLA-4, PD-1, and BTLA have recently drawn much attention as potential targets for immunotherapies. This review focuses on the progress that has been made with the mentioned receptors in the field of immunotherapies for autoimmune diseases, malignancies, infectious diseases, and transplantation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available